Methods for determining the outcome for patients with prostatic disease

摘要

And to provide a method for the prognosis of patients with (localized prostate cancer clinically, for example) prostate cancer. The present invention provides a method for determining the risk of progression of prostate cancer patients after treatment, That before the treatment for localized prostate cancer (a) clinically, and detecting or measuring the amount or level of sVCAM VEGF in the blood sample obtained from the patient, UPAR, or UPA,, and (b) the VEGF , including that associated with risk of progression the amount or level of sVCAM UPAR, or UPA,, it also relates to a method.